We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Patent expirations, biosimilars and uncertainty around the Trump administration’s drug policies will create a pricing squeeze in the drug industry, according to a new analysis. Read More
Pharmakon Pharmaceuticals executives routinely sent drugs to hospitals without waiting for test results confirming the potency of the drugs matched their labels, and when results showed the strength was often nearly double what it should have been, covered up the error and lied to FDA investigators rather than notifying the FDA or customers, according to a 10-count federal indictment. Read More
Senate Republicans unveiled their hotly anticipated version of a bill to replace the Affordable Care Act Thursday, which includes the repeal of a pharmaceutical industry tax. Read More
A trio of individual pharmaceutical recalls swept through the industry last week, spotlighting a variety of formulation and quality control issues at major drugmakers. Read More